Global Intravenous Infusion Pumps Market by Product (Enteral, Volumetric, Syringe, Implantable Pumps, Ambulatory, Insulin) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global intravenous infusion pump market was valued at USD4.6 billion in 2020. It is expected to grow at a compound annual rate (CAGR of 7.9%) between 2021 and 2028. Infusion pumps are used extensively in hospitals, nursing homes, and at home. The trained operator can program the pump's rate and duration using built-in software. This allows the pumps to deliver nutrients, hormones and pain relief.

Due to their ability to deliver exact doses at predetermined times, the COVID-19 pandemic has led to an increase of intravenous pump and related equipment. These intravenous injection pumps are used to deliver a variety of medications, including antithrombotic, vasopressors and insulin. They also aid in the delivery anesthetics, neuromuscular blocking drugs, and antiarrhythmic medicines. Many of these medications are required for COVID-19 patients.

The leading cause of death and disability in the world are chronic diseases. 80% of all deaths from these diseases are caused by chronic diseases. According to WHO, cardiovascular diseases, strokes, cancer and chronic respiratory diseases are all considered chronic diseases. Diabetes is the leading cause of death worldwide. According to NCBI, the world's burden of cancer has increased dramatically. It was 18.1 million cases worldwide in 2018. These diseases are a serious public health problem and require a fast and controlled treatment. There has been an increase in the demand for intravenous pump devices due to rising incidences of cancer and cardiovascular diseases.

An increasing number of diseases means that medication errors are possible. Advanced delivery systems are needed that are safer, more efficient, and more standardized. There are greater opportunities for growth in the market through the introduction of next-generation intravenous pump or smart intravenous injection pumps. Smart pumps are intravenous infusion devices with embedded computer software that reduces drug dosing errors. They are equipped with drug libraries to ensure safe medication administration.

These intravenous pumps are used in continuous infusion therapy to deliver chemotherapeutic drugs or intermittent therapy for antibiotic delivery. According to NCBI, ambulatory pumps are becoming more popular each year. Market growth will be driven by factors such as the growing geriatric population, chronic diseases prevalence, and low price. Market growth will also be influenced by a rising number of people undergoing surgery for cancer, heart disease, and other conditions.

Product Insights

Over the forecast period, insulin infusion pumps will experience a 8.5% CAGR. The market can be segmented by product into volumetric and syringe insulin pumps, insulin pumps, syringe pumps, insulin pumps, enteral pumps pumps, ambulatory pumps, patient-controlled infusion pump, implantable pumps, and infusion pump pumps.

The International Diabetes Federation (IDF) estimates that nearly 463 million people worldwide had diabetes in 2019. This number will rise to 700 million by 2045, according to IDF. For people who need to self-medicate insulin daily, insulin infusion pumps are a great option. A Insulin pump is small, computer-controlled device that delivers short-acting insulin continuously through a thin tube. It replaces the need to have a longer-acting one. A continuous insulin injection replaces multiple daily injections by an insulin pump.

Smart pumps that can control IV medication and have error-prevention software have been popular lately. These intravenous pumps come with advanced features such as drug libraries which allow for the storage of patient's dose and barcode technology which allows for the verification of patient identity and helps to prevent errors in drug administration.

Indications of disease

The Paediatrics/Neonatology segment was identified as the largest segment with 27.0% revenue share in 2020 followed by gastroenterology. On the basis of disease indication, the market has been segmented into chemotherapy diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and others.

According to NCBI, 85.29 Million cases of digestive disorders were reported in 2017. This number is expected to rise over the next few years. Colorectal cancer is the leading cause of death due to GI issues. Pancreatic cancer and hepatobiliary neoplasms are next. NCBI's statistical analysis revealed that the disease is more common in women and is associated with factors like smoking, alcohol consumption, unhealthy living conditions, and high intake of spicy and/or fermented foods.

A branch of medicine, neonatology, deals with infants born to/with severe conditions such as prematurity or low birth weight, intrauterine restriction, congenital malformations, birth defects, sepsis, hypoplasia, and birth asphyxia. The WHO estimates that 15 million babies are born prematurely, making it the leading cause of infant deaths worldwide. With cost-effective, feasible care and nutrition during the first stages of birth, preterm babies can be reduced by almost three quarters.

Regional Insights

North America was the dominant market for intravenous infusion pumps and held the largest revenue share at 49.3% in 2020. This segment is expected to continue growing over the forecast period. This is due to factors like a developed medical infrastructure, high chronic diseases burden, and advances in infusion technology. In the future, the market will be driven by factors like favorable insurance policies and reimbursement policies for medical devices, strong local presences of key manufacturers, major exporters of intravenous injection pumps, and strong local presences of key suppliers.

The market in Asia Pacific is expected to experience the highest CAGR at 8.4% during the forecast period. This is due to rising rates of diabetes and chronic diseases like cancer, increasing number of surgeries performed, rapid adoption and regional presence of global players. These factors will create lucrative opportunities for Asia Pacific's market during the forecast period.

Market Share Insights & Key Companies

The intravenous infusion pump market is very competitive. The market is highly competitive due to the adoption of advanced healthcare technology and automation. To retain market share, major players will often choose to expand geographically. Companies are also adopting new product launches and mergers to expand their product range. Medtronic, for example, announced in April 2021 that it would be launching an extended infusion set in select European nations. Patients with diabetes can wear this infusion set for up to 7 days. This allows them to continue intravenous pump therapy without interruptions or insertions. The market leader in intravenous infusion pumps is:

• Baxter International

• B. Braun Melsungen AG

• Medtronic

• Micrel Medical Devices SA

• Boston Scientific Corporation

• CareFusion Corporation

• Fresenius Kabi

• Smiths Medical

Up Market Research published a new report titled “Intravenous Infusion Pumps Market research report which is segmented by Product (Enteral, Volumetric, Syringe, Implantable Pumps, Ambulatory, Insulin), By Players/Companies Baxter International, Micrel Medical Devices SA, Fresenius Kabi, CareFusion Corporation, Medtronic, Boston Scientific Corporation, B Braun Melsungen AG, Smiths Medical”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Intravenous Infusion Pumps Market Report Segments:

The market is segmented by Product (Enteral, Volumetric, Syringe, Implantable Pumps, Ambulatory, Insulin).

Intravenous Infusion Pumps Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Intravenous Infusion Pumps Market

Overview of the regional outlook of the Intravenous Infusion Pumps Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Intravenous Infusion Pumps Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Intravenous Infusion Pumps Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Enteral

                2. Volumetric

                3. Syringe

                4. Implantable Pumps

                5. Ambulatory

                6. Insulin

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Intravenous Infusion Pumps Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Intravenous Infusion Pumps Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.